copper histidine
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 1990 (NCT00001262)
Timeline
Indications
Mechanism of action
- CopperSupplementation
Copper supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297731 ↗
Also known as
- copper histidine
- copper histidine
- copper histidine
- cu-his
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00811785 | Phase 3 | Dec 17, 2008 | National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH) |
| NCT00001262 | Phase 1/Phase 2 (Phase 2) | Jun 1, 1990 | National Institutes of Health (NIH) |
| NCT04074512 | N/A | — | Fortress Biotech |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institutes of Health (NIH) | Government | 2 | 2 | 2 | 1990 |
| Fortress Biotech | For profit | 1 | 1 | 1 | — |
| National Center for Complementary and Integrative Health (NCCIH) | Government | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1